Affiliation:
1. Molecular and Cellular Biochemistry Department, Indiana University, Bloomington, Indiana, USA
2. McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
Abstract
ABSTRACT
Capsid (core) assembly is essential for hepatitis B virus (HBV) replication. We hypothesize that assembly kinetics and stability are tuned for optimal viral replication, not maximal assembly. Assembly effectors (AEfs) are small molecules proposed to disrupt this balance by inappropriately enhancing core assembly. Guided by the structure of an AEf-bound core, we designed a structural mimic of AEf-bound core protein, the V124W mutant. In biochemical studies, the V124W mutant recapitulated the effects of AEfs, with fast assembly kinetics and a strong protein-protein association energy. Also, the mutant was resistant to exogenous AEfs. In cell culture, the V124W mutant behaved like a potent AEf: expression of HBV carrying the V124W mutant was defective for genome replication. Critically, the V124W mutant interfered with replication of wild-type HBV in a dose-dependent manner, mimicking AEf activity. In addition, the V124W mutant was shown to adopt a more compact conformation than that of the wild type, confirming the allosteric regulation in capsid assembly. These studies show that the heteroaryldihydropyrimidine (HAP) binding pocket is a promiscuous target for inducing assembly. Suppression of viral replication by the V124W mutant suggests that mutations that fill the HAP site are not a path for HBV to escape from AEfs.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference44 articles.
1. ColvinHM MitchellAE (ed). 2010. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. National Academies Press, Washington, DC.
2. WHO position on the use of hepatitis B vaccines;WHO;Wkly. Epidemiol. Rec.,2004
3. Antiviral therapy and resistance with hepatitis B virus infection;Tillmann HL;World J. Gastroenterol.,2007
4. Hepatitis B therapy;Kwon H;Nat. Rev. Gastroenterol. Hepatol.,2011
5. Hepatitis B virus infection—natural history and clinical consequences;Ganem D;N. Engl. J. Med.,2004
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献